This National Institute on Alcohol Abuse and Alcoholism (NIAAA) grant is for supporting research focused on prevention and intervention strategies for Fetal Alcohol Spectrum Disorders (FASD) across the lifespan. The primary purpose of this funding opportunity is to advance effective approaches to reduce prenatal alcohol exposure and the incidence of FASD, alongside developing robust interventions for individuals affected by FASD. Utilizing the Exploratory/Developmental Phased Award (R61/R33) mechanism, the grant first supports pilot studies or secondary data analysis for hypothesis development and feasibility in the R61 phase. Successful R61 projects can transition to the R33 phase for expanded research, contingent on achieving milestones evaluated by NIAAA staff. Applications proposing clinical trials will receive the highest priority.
Opportunity ID: 330357
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-098 |
| Funding Opportunity Title: | Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.273 — Alcohol Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 11, 2020 |
| Last Updated Date: | Dec 11, 2020 |
| Original Closing Date for Applications: | Oct 17, 2023 |
| Current Closing Date for Applications: | Oct 17, 2023 |
| Archive Date: | Nov 22, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | State governments Native American tribal governments (Federally recognized) County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Private institutions of higher education City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Special district governments For profit organizations other than small businesses Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The intent of this FOA is to support research that advances (1) prevention approaches to reduce prenatal alcohol exposure and the incidence of FASD and that (2) interventions for FASD. These objectives will be accomplished with the Exploratory/Developmental Phased Award (R61/R33) mechanism, clinical trial optional. The R61 phase will support pilot studies or secondary data analysis for hypothesis development and feasibility, and research testing the hypotheses can be expanded in the R33 phase. The transition to the R33 phase will be determined by NIAAA program staff after evaluation of the achievement of specific milestones set for the R61 phase. Highest priority will be given to applications with clinical trials. Applicants interested in planning clinical trials or adding to current projects may also consider FOA (PAR-21-NNN, the R34 option). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-098.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 330357 Full Announcement-PAR-21-098 -> PAR-21-098-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00264455 | Jan 19, 2021 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00270590 | Nov 22, 2021 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278340 | Nov 14, 2022 | Oct 17, 2023 | View |
Package 1
Mandatory forms
330357 RR_SF424_2_0-2.0.pdf
330357 PHS398_CoverPageSupplement_5_0-5.0.pdf
330357 RR_OtherProjectInfo_1_4-1.4.pdf
330357 PerformanceSite_2_0-2.0.pdf
330357 RR_KeyPersonExpanded_2_0-2.0.pdf
330357 RR_Budget_1_4-1.4.pdf
330357 PHS398_ResearchPlan_4_0-4.0.pdf
330357 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
330357 RR_SubawardBudget30_1_4-1.4.pdf
330357 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
330357 RR_SF424_5_0-5.0.pdf
330357 PHS398_CoverPageSupplement_5_0-5.0.pdf
330357 RR_OtherProjectInfo_1_4-1.4.pdf
330357 PerformanceSite_4_0-4.0.pdf
330357 RR_KeyPersonExpanded_4_0-4.0.pdf
330357 RR_Budget_3_0-3.0.pdf
330357 PHS398_ResearchPlan_4_0-4.0.pdf
330357 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
330357 RR_SubawardBudget30_3_0-3.0.pdf
330357 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
330357 RR_SF424_5_0-5.0.pdf
330357 PHS398_CoverPageSupplement_5_0-5.0.pdf
330357 RR_OtherProjectInfo_1_4-1.4.pdf
330357 PerformanceSite_4_0-4.0.pdf
330357 RR_KeyPersonExpanded_4_0-4.0.pdf
330357 RR_Budget_3_0-3.0.pdf
330357 PHS398_ResearchPlan_5_0-5.0.pdf
330357 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
330357 RR_SubawardBudget30_3_0-3.0.pdf
330357 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
